Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
- 21 July 2011
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 29 (42), 7251-7260
- https://doi.org/10.1016/j.vaccine.2011.07.020
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus MacaquesThe American Journal of Tropical Medicine and Hygiene, 2011
- Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexesThe Lancet Infectious Diseases, 2010
- Update on the global spread of dengueInternational Journal of Antimicrobial Agents, 2010
- Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeysVaccine, 2010
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue VirusJournal of Virology, 2008
- DengueThe Lancet, 2007
- Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus SerotypesClinical and Vaccine Immunology, 2007
- Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigenVaccine, 2006
- DengueCurrent Opinion in Infectious Diseases, 2002
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersVaccine, 2001